- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/02 - 1,2-OxazinesHydrogenated 1,2-oxazines
Patent holdings for IPC class C07D 265/02
Total number of patents in this class: 48
10-year publication summary
|
1
|
2
|
4
|
2
|
4
|
2
|
4
|
5
|
7
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1433 |
6 |
| Syngenta Crop Protection AG | 6818 |
4 |
| Bayer Schering Pharma AG | 291 |
4 |
| BioMarin Pharmaceutical Inc. | 400 |
4 |
| Adeka Corporation | 1388 |
3 |
| Nihon Nohyaku Co., Ltd. | 326 |
3 |
| Paratek Pharmaceuticals, Inc. | 104 |
3 |
| Novartis AG | 10160 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 659 |
2 |
| Abbott Laboratories | 2229 |
1 |
| Chlorion Pharma, Inc. | 3 |
1 |
| Enanta Pharmaceuticals, Inc. | 427 |
1 |
| FMC Corporation | 817 |
1 |
| Howard University | 201 |
1 |
| Kyowa Hakko Kirin Co., Ltd. | 262 |
1 |
| Mintz Levin Cohn Ferris Glovsky and Popeo PC | 19 |
1 |
| Nanjing Cavendish Bio-Engineering Technology Co., Ltd. | 20 |
1 |
| Promega Corporation | 574 |
1 |
| SDS Biotech K.K. | 104 |
1 |
| Sekisui Chemical Co., Ltd. | 3669 |
1 |
| Other owners | 6 |